Cargando…

Response to The challenges of diagnosing heparin‐induced thrombocytopenia in patients with COVID‐19

Detalles Bibliográficos
Autores principales: Riker, Richard R., May, Teresa L., Fraser, Gilles L., Gagnon, David J., Bandara, Mahesh, Zemrak, Wes, Seder, David B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361545/
https://www.ncbi.nlm.nih.gov/pubmed/32838110
http://dx.doi.org/10.1002/rth2.12417
_version_ 1783559380996718592
author Riker, Richard R.
May, Teresa L.
Fraser, Gilles L.
Gagnon, David J.
Bandara, Mahesh
Zemrak, Wes
Seder, David B.
author_facet Riker, Richard R.
May, Teresa L.
Fraser, Gilles L.
Gagnon, David J.
Bandara, Mahesh
Zemrak, Wes
Seder, David B.
author_sort Riker, Richard R.
collection PubMed
description
format Online
Article
Text
id pubmed-7361545
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-73615452020-07-15 Response to The challenges of diagnosing heparin‐induced thrombocytopenia in patients with COVID‐19 Riker, Richard R. May, Teresa L. Fraser, Gilles L. Gagnon, David J. Bandara, Mahesh Zemrak, Wes Seder, David B. Res Pract Thromb Haemost Letters to the Editor John Wiley and Sons Inc. 2020-08-04 /pmc/articles/PMC7361545/ /pubmed/32838110 http://dx.doi.org/10.1002/rth2.12417 Text en © 2020 The Authors. Research and Practice in Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Letters to the Editor
Riker, Richard R.
May, Teresa L.
Fraser, Gilles L.
Gagnon, David J.
Bandara, Mahesh
Zemrak, Wes
Seder, David B.
Response to The challenges of diagnosing heparin‐induced thrombocytopenia in patients with COVID‐19
title Response to The challenges of diagnosing heparin‐induced thrombocytopenia in patients with COVID‐19
title_full Response to The challenges of diagnosing heparin‐induced thrombocytopenia in patients with COVID‐19
title_fullStr Response to The challenges of diagnosing heparin‐induced thrombocytopenia in patients with COVID‐19
title_full_unstemmed Response to The challenges of diagnosing heparin‐induced thrombocytopenia in patients with COVID‐19
title_short Response to The challenges of diagnosing heparin‐induced thrombocytopenia in patients with COVID‐19
title_sort response to the challenges of diagnosing heparin‐induced thrombocytopenia in patients with covid‐19
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361545/
https://www.ncbi.nlm.nih.gov/pubmed/32838110
http://dx.doi.org/10.1002/rth2.12417
work_keys_str_mv AT rikerrichardr responsetothechallengesofdiagnosingheparininducedthrombocytopeniainpatientswithcovid19
AT mayteresal responsetothechallengesofdiagnosingheparininducedthrombocytopeniainpatientswithcovid19
AT frasergillesl responsetothechallengesofdiagnosingheparininducedthrombocytopeniainpatientswithcovid19
AT gagnondavidj responsetothechallengesofdiagnosingheparininducedthrombocytopeniainpatientswithcovid19
AT bandaramahesh responsetothechallengesofdiagnosingheparininducedthrombocytopeniainpatientswithcovid19
AT zemrakwes responsetothechallengesofdiagnosingheparininducedthrombocytopeniainpatientswithcovid19
AT sederdavidb responsetothechallengesofdiagnosingheparininducedthrombocytopeniainpatientswithcovid19